Published in Minerva Pediatr on December 10, 1996
Are inhaled corticosteroids associated with an increased risk of fracture in children? Osteoporos Int (2004) 0.96
An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell (1987) 3.78
Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci U S A (1997) 2.36
Analysis of RAS oncogene mutations in human lymphoid malignancies. Proc Natl Acad Sci U S A (1988) 2.01
Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL): results of a prospective, single-arm multicentre study. Leukemia (2009) 1.80
Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther (1994) 1.79
Helical CT angiography in gastrointestinal bleeding of obscure origin. AJR Am J Roentgenol (1997) 1.58
A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes. Br J Haematol (1998) 1.55
Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features. Haematologica (1998) 1.49
Risk of second cancers in Waldenström macroglobulinemia. Ann Oncol (2011) 1.47
Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines. Leuk Res (2010) 1.40
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy. Haematologica (1999) 1.39
Increased CD10/TdT positive cells in the bone marrow of an infant with immune thrombocytopenia. Haematologica (1994) 1.38
Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma. Ann Oncol (2008) 1.34
Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res (1995) 1.33
Loss of function effect of RET mutations causing Hirschsprung disease. Nat Genet (1995) 1.33
Molecular cloning of a gene that is necessary for G1 progression in mammalian cells. Proc Natl Acad Sci U S A (1987) 1.29
Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations. Oncogene (2001) 1.25
Risk of childhood cancer and adult lung cancer after childhood exposure to passive smoke: A meta-analysis. Environ Health Perspect (2000) 1.24
Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study. Radiology (2000) 1.21
Detection of haemoparasites in cattle by reverse line blot hybridisation with a note on the distribution of ticks in Sicily. Vet Parasitol (2001) 1.18
Alternative splicing of the ErbB-4 cytoplasmic domain and its regulation by hedgehog signaling identify distinct medulloblastoma subsets. Oncogene (2006) 1.18
Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients. Oncogene (2006) 1.17
Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome. Ann Hematol (2004) 1.14
The oncogenic versions of the Ret and Trk tyrosine kinases bind Shc and Grb2 adaptor proteins. Oncogene (1994) 1.14
Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells. Genes Chromosomes Cancer (1996) 1.13
Numb activates the E3 ligase Itch to control Gli1 function through a novel degradation signal. Oncogene (2010) 1.12
Translation initiation of the insulin-like growth factor I receptor mRNA is mediated by an internal ribosome entry site. J Biol Chem (2000) 1.11
Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia. Br J Haematol (2001) 1.08
PDGFRalpha, PDGFRbeta and KIT expression/activation in conventional chondrosarcoma. J Pathol (2006) 1.08
RET activation by germline MEN2A and MEN2B mutations. Oncogene (1995) 1.07
Primary plasma cell leukemia: a retrospective multicenter study of 73 patients. Ann Oncol (2011) 1.07
FK506 binding protein 51 positively regulates melanoma stemness and metastatic potential. Cell Death Dis (2013) 1.06
IGFBP7: an oncosuppressor gene in thyroid carcinogenesis. Oncogene (2010) 1.05
The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi. Ann Oncol (2013) 1.05
Isolation of the human gene that complements a temperature-sensitive cell cycle mutation in BHK cells. Mol Cell Biol (1987) 1.04
Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party. Ann Oncol (2011) 1.02
Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story. Ann Oncol (2009) 1.01
Detection of novel mRNA splice variants of human ING4 tumor suppressor gene. Oncogene (2007) 1.00
PCAF ubiquitin ligase activity inhibits Hedgehog/Gli1 signaling in p53-dependent response to genotoxic stress. Cell Death Differ (2013) 1.00
Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease. Blood (2001) 0.99
Two different ionotropic receptors are activated by ATP in rat microglia. J Physiol (1999) 0.97
Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders. Am J Hematol (2000) 0.97
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine. Leukemia (2011) 0.97
Rearrangements of TRK proto-oncogene in papillary thyroid carcinomas. J Endocrinol Invest (1995) 0.96
The gene complementing a temperature-sensitive cell cycle mutant of BHK cells is the human homologue of the yeast RPC53 gene, which encodes a subunit of RNA polymerase C (III). Cell Growth Differ (1993) 0.96
Translational control of viral and host protein synthesis during the course of herpes simplex virus type 1 infection: evidence that initiation of translation is the limiting step. J Gen Virol (1998) 0.96
Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response. J Eur Acad Dermatol Venereol (2010) 0.96
Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulation (1997) 0.96
Human umbilical cord blood: immunophenotypic heterogeneity of CD34+ hematopoietic progenitor cells. Haematologica (1997) 0.94
The 3' untranslated region of the B19 parvovirus capsid protein mRNAs inhibits its own mRNA translation in nonpermissive cells. J Virol (1997) 0.94
Increased brain synthesis of prostaglandin E2 and F2-isoprostane in human and experimental transmissible spongiform encephalopathies. J Neuropathol Exp Neurol (2000) 0.94
Down-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1. Br J Pharmacol (1999) 0.94
Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulation. Oncogene (1998) 0.92
Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and beta2-microglobulin in B-cell chronic lymphocytic leukemia. Eur J Haematol (1999) 0.92
High risk of early resistant relapse for leukaemic patients with presence of multidrug resistance associated P-glycoprotein positive cells in complete remission. Br J Haematol (1991) 0.91
TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells. Oncogene (2011) 0.91
CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia. Leuk Lymphoma (2001) 0.91
In vivo activation of N-methyl-D-aspartate receptors in the rat hippocampus increases prostaglandin E(2) extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms. J Neurochem (2002) 0.91
Increased CSF levels of prostaglandin E(2) in variant Creutzfeldt-Jakob disease. Neurology (2002) 0.91
Spontaneous remission in acute myeloid leukaemia: a role for endogenous production of tumour necrosis factor and interleukin-2? Br J Haematol (1994) 0.90
Simvastatin protection against acute immune-mediated glomerulonephritis in mice. Kidney Int (2006) 0.90
BK virus infection in AIDS. Am J Surg Pathol (2000) 0.90
Blood cell flow cytometry in paroxysmal nocturnal hemoglobinuria: a tool for measuring the extent of the PNH clone. Leukemia (1996) 0.89
The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium. Oncogene (2000) 0.89
Malignant cardiac myxoma with cerebral metastases. Surg Neurol (1979) 0.89
CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype. Haematologica (1998) 0.88
Induction of prostaglandin endoperoxide synthase-2 in human monocytes associated with cyclo-oxygenase-dependent F2-isoprostane formation. Br J Pharmacol (1996) 0.88
Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions. AJR Am J Roentgenol (2000) 0.88
Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance. Diabetologia (2011) 0.88
Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients. Leukemia (2012) 0.88
Serum levels of cytokines and soluble antigens in polytransfused patients with beta-thalassemia major: relationship to immune status. Haematologica (1995) 0.87
Universal newborn hearing screening programs in Italy: survey of year 2006. Acta Otolaryngol (2008) 0.87
Influence of cognitive impairment and comorbidity on disability in hospitalized elderly patients. J Nutr Health Aging (2005) 0.86
Potentiometric determination of carbonic anhydrase activity in rabbit carotid bodies: comparison among normoxic, hyperoxic and hypoxic animals. Neurosci Lett (1994) 0.86
Frailty syndrome is associated with altered circulating redox balance and increased markers of oxidative stress. Int J Immunopathol Pharmacol (2009) 0.86
Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy. Leukemia (2011) 0.86
Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome. Blood (1998) 0.86
A novel NTRK1 mutation associated with congenital insensitivity to pain with anhidrosis. Am J Hum Genet (1999) 0.86
Interacting with γ-secretase for treating Alzheimer's disease: from inhibition to modulation. Curr Med Chem (2011) 0.85
IRS-1 and IRS-2 are recruited by TrkA receptor and oncogenic TRK-T1. J Cell Physiol (2001) 0.85
Circulating regulatory T cells in "clinical" monoclonal B-cell lymphocytosis. Int J Immunopathol Pharmacol (2012) 0.85
Deletion of the lifespan determinant p66(Shc) improves performance in a spatial memory task, decreases levels of oxidative stress markers in the hippocampus and increases levels of the neurotrophin BDNF in adult mice. Exp Gerontol (2007) 0.85
The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL). Ann Oncol (2014) 0.85
Dysphagia in amyotrophic lateral sclerosis: prevalence and clinical findings. Acta Neurol Scand (2013) 0.84
Biliary lipid secretion: immunolocalization and identification of a protein associated with lamellar cholesterol carriers in supersaturated rat and human bile. J Lipid Res (1993) 0.84
Hepatitis C virus infection: a new bridge between hematologists and gastroenterologists? Blood (1996) 0.84
Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/m(2)). Leukemia (2004) 0.84
Time-related dynamics of variation in core clock gene expression levels in tissues relevant to the immune system. Int J Immunopathol Pharmacol (2012) 0.84
Magnetic resonance imaging in neurosarcoidosis. Magn Reson Imaging (1987) 0.84
Laryngotracheal stenosis treated with multiple surgeries: experience, results and prognostic factors in 70 patients. Acta Otorhinolaryngol Ital (2012) 0.84
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets. Oncogene (2011) 0.84
Vaccination against influenza in multiple myeloma. Br J Haematol (1997) 0.83
Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus. Fetal Pediatr Pathol (2005) 0.83
Treatment of cancer anorexia with megestrol acetate: impact on quality of life. Oncology (Williston Park) (1990) 0.83
Prognosis of chronic myelomonocytic leukemia. Haematologica (1996) 0.83
Calcified gastric cancer: report of a case and review of literature. Br J Radiol (1986) 0.83
Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation. Transpl Infect Dis (2007) 0.83
Morphologically typical and atypical B-cell chronic lymphocytic leukemias display a different pattern of surface antigenic density. Leuk Lymphoma (2001) 0.83